Browsing byAuthorBillot, L

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
2022-08-29Age-Related Variation in the Provision of Primary Care Services and Medication Prescriptions for Patients with Cardiovascular Disease.Tu, Q; Hyun, K; Hafiz, N; Knight, A; Hespe, C; Chow, CK; Briffa, T; Gallagher, R; Reid, CM; Hare, DL; Zwar, N; Woodward, M; Jan, S; Atkins, ER; Laba, T-L; Halcomb, E; Usherwood, T; Billot, L; Redfern, J
2020-11Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial.Wang, N; Salam, A; Webster, R; de Silva, A; Guggilla, R; Stepien, S; Mysore, J; Billot, L; Jan, S; Maulik, PK; Naik, N; Selak, V; Thom, S; Prabhakaran, D; Patel, A; Rodgers, A; TRIUMPH Study Group
2017-06-22Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke.Anderson, CS; Arima, H; Lavados, P; Billot, L; Hackett, ML; Olavarría, VV; Muñoz Venturelli, P; Brunser, A; Peng, B; Cui, L; Song, L; Rogers, K; Middleton, S; Lim, JY; Forshaw, D; Lightbody, CE; Woodward, M; Pontes-Neto, O; De Silva, HA; Lin, R-T; Lee, T-H; Pandian, JD; Mead, GE; Robinson, T; Watkins, C; HeadPoST Investigators and Coordinators,
2022-05-17Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.Lv, J; Wong, MG; Hladunewich, MA; Jha, V; Hooi, LS; Monaghan, H; Zhao, M; Barbour, S; Jardine, MJ; Reich, HN; Cattran, D; Glassock, R; Levin, A; Wheeler, DC; Woodward, M; Billot, L; Stepien, S; Rogers, K; Chan, TM; Liu, Z-H; Johnson, DW; Cass, A; Feehally, J; Floege, J; Remuzzi, G; Wu, Y; Agarwal, R; Zhang, H; Perkovic, V; TESTING Study Group,
2017-06-23Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular diseaseAngell, B; Laba, TL; Lung, T; Brown, A; Eades, S; Usherwood, T; Peiris, D; Billot, L; Hillis, G; Webster, R; Tonkin, A; Reid, C; Molanus, B; Rafter, N; Cass, A; Patel, A; Jan, S
2019-03-01Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational studyJun, M; Jardine, MJ; Perkovic, V; Pilard, Q; Billot, L; Rodgers, A; Rogers, K; Gallagher, M
2021Influence of Including Patients with Premorbid Disability in Acute Stroke Trials: The HeadPoST Experience.Wang, X; Moullaali, TJ; Ouyang, M; Billot, L; Sandset, EC; Song, L; Delcourt, C; Hackett, ML; Watkins, CL; Robinson, TG; Yang, J; Lavados, PM; Brunser, A; Olavarría, VV; Muñoz-Venturelli, P; Arima, H; Middleton, S; Pontes-Neto, OM; Pandian, JD; Rogers, K; Anderson, CS
2021-09-18Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.Chow, CK; Atkins, ER; Hillis, GS; Nelson, MR; Reid, CM; Schlaich, MP; Hay, P; Rogers, K; Billot, L; Burke, M; Chalmers, J; Neal, B; Patel, A; Usherwood, T; Webster, R; Rodgers, A; QUARTET Investigators,
2020-02-14QUality improvement in primary care to prevent hospitalisations and improve Effectiveness and efficiency of care for people Living with coronary heart disease (QUEL): protocol for a 24-month cluster randomised controlled trial in primary care.Redfern, J; Hafiz, N; Hyun, K; Knight, A; Hespe, C; Chow, CK; Briffa, T; Gallagher, R; Reid, C; Hare, DL; Zwar, N; Woodward, M; Jan, S; Atkins, ER; Laba, T-L; Halcomb, E; Billot, L; Johnson, T; Usherwood, T
2020-10-02Ultra-low-dose quadruple combination blood pressure lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol.Chow, CK; Atkins, ER; Billot, L; Chalmers, J; Hillis, GS; Hay, P; Neal, B; Nelson, M; Patel, A; Reid, CM; Schlaich, M; Usherwood, T; Webster, R; Rodgers, A